Reporting
Seek and Treat for Optimal outcomes and Prevention in HIV& AIDS in IDU
Learn MoreReporting
Predictors of antiretroviral pharmacokinetics in HIV-infected women with virologic suppression on combination antiretroviral therapy
Learn MoreCompleted
A Phase II, prospective, open-label, pilot study of the tolerability, safety, and efficacy of Argon plasma coagulation for the treatment of anal intraepithelial neoplasia grade 2 or 3 in HIV-positive men having sex with men
Learn MoreReporting
Disentangling medicinal and non-medicinal cannabis use among people living with HIV: Feasibility of a smartphone-based assessment
Learn MoreCompleted
Feasibility of Crystal Methamphetamine Interventions Among Gay, Bisexual and Other Men Who Have Sex With Men in Canada
Learn MoreReporting
The impact of in-clinic follow-up with a sexologist on the sexual health of HIV-serodiscordant MSM couples
Learn MoreCompleted
Effects of HLA allele frequencies on HIV disease progression and viral load among newly diagnosed HIV infected individuals in Manitoba: Trial Results
Learn MoreReporting
Bone and renal outcomes in HIV-exposed uninfected infants with perinatal exposure to tenofovir
Learn More
CTN Trials have been approved by the Community Advisory Committee of the Canadian HIV Trials Network and the Network’s Scientific Review Committee, or other national peer-review panels such as those at the Canadian Institutes of Health Research and the U.S. National Institutes of Health. CTNPT studies are small-scale investigations designed to determine the feasibility of research concepts, and do not all go through the regular CTN clinical trial review process. For information on the benefits and risks of participating in HIV clinical trials, call CATIE toll-free at 1-800-263-1638.
